BioTelemetry Company Profile (NASDAQ:BEAT)

About BioTelemetry (NASDAQ:BEAT)

BioTelemetry logoBioTelemetry, Inc. (BioTelemetry), formerly CardioNet, Inc., provides cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The Company operates in three segments: patient services, product and research services. The patient services business segment's principal focus is on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders, through its core Mobile Cardiac Outpatient Telemetry(MCOT), event and Holter services in a healthcare setting. The product business segment focuses on the development, manufacturing, testing and marketing of medical devices to medical companies, clinics and hospitals. The Company's research services focuses on providing cardiac safety monitoring services for drug and medical treatment trials in a research environment. In August 2012, the Company completed the acquisition of Cardiocore Lab, Inc. (Cardiocore).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Symbol: NASDAQ:BEAT
  • CUSIP: N/A
  • Web: www.gobio.com
Capitalization:
  • Market Cap: $985.73 million
  • Outstanding Shares: 28,655,000
Average Prices:
  • 50 Day Moving Avg: $31.17
  • 200 Day Moving Avg: $27.89
  • 52 Week Range: $15.25 - $35.60
P/E:
  • Trailing P/E Ratio: 21.23
  • Foreward P/E Ratio: 30.18
  • P/E Growth: 1.82
Sales & Book Value:
  • Annual Revenue: $205.49 million
  • Price / Sales: 4.80
  • Book Value: $4.99 per share
  • Price / Book: 6.89
Profitability:
  • EBIDTA: $39.1 million
  • Net Margins: 22.77%
  • Return on Equity: 19.87%
  • Return on Assets: 12.76%
Debt:
  • Debt-to-Equity Ratio: 0.16%
  • Current Ratio: 1.89%
  • Quick Ratio: 1.76%
Misc:
  • Average Volume: 523,049 shs.
  • Beta: 0.76
  • Short Ratio: 4.04
 
Frequently Asked Questions for BioTelemetry (NASDAQ:BEAT)

What is BioTelemetry's stock symbol?

BioTelemetry trades on the NASDAQ under the ticker symbol "BEAT."

How were BioTelemetry's earnings last quarter?

BioTelemetry, Inc. (NASDAQ:BEAT) posted its earnings results on Wednesday, May, 3rd. The company reported $0.16 EPS for the quarter, topping the Zacks' consensus estimate of $0.14 by $0.02. The business had revenue of $55.88 million for the quarter, compared to analysts' expectations of $55.11 million. BioTelemetry had a return on equity of 19.87% and a net margin of 22.77%. View BioTelemetry's Earnings History.

When will BioTelemetry make its next earnings announcement?

BioTelemetry is scheduled to release their next quarterly earnings announcement on Monday, July, 31st 2017. View Earnings Estimates for BioTelemetry.

Where is BioTelemetry's stock going? Where will BioTelemetry's stock price be in 2017?

5 analysts have issued twelve-month price objectives for BioTelemetry's shares. Their forecasts range from $27.00 to $50.00. On average, they expect BioTelemetry's share price to reach $39.50 in the next twelve months. View Analyst Ratings for BioTelemetry.

Are investors shorting BioTelemetry?

BioTelemetry saw a increase in short interest during the month of June. As of June 15th, there was short interest totalling 1,666,260 shares, an increase of 34.5% from the May 31st total of 1,238,821 shares. Based on an average daily trading volume, of 478,802 shares, the short-interest ratio is currently 3.5 days. Approximately 6.0% of the company's stock are short sold.

Who are some of BioTelemetry's key competitors?

Who owns BioTelemetry stock?

BioTelemetry's stock is owned by a number of of institutional and retail investors. Top institutional investors include Summit Creek Advisors LLC (1.19%), Bank of Montreal Can (0.21%), Insight Capital Research & Management Inc. (0.14%), Aperio Group LLC (0.09%), Concorde Asset Management LLC (0.09%) and Capstone Asset Management Co. (0.06%). Company insiders that own BioTelemetry stock include Daniel Wisniewski, Fred Broadway, George Hrenko, Heather C Getz, Joseph H Capper, Peter Ferola and Robert J Rubin. View Institutional Ownership Trends for BioTelemetry.

Who sold BioTelemetry stock? Who is selling BioTelemetry stock?

BioTelemetry's stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Capstone Asset Management Co. and LS Investment Advisors LLC. Company insiders that have sold BioTelemetry stock in the last year include Daniel Wisniewski, Fred Broadway, George Hrenko, Heather C Getz, Joseph H Capper, Peter Ferola and Robert J Rubin. View Insider Buying and Selling for BioTelemetry.

Who bought BioTelemetry stock? Who is buying BioTelemetry stock?

BioTelemetry's stock was bought by a variety of institutional investors in the last quarter, including Summit Creek Advisors LLC, Insight Capital Research & Management Inc., Aperio Group LLC, Concorde Asset Management LLC, Curbstone Financial Management Corp, US Bancorp DE, Dubuque Bank & Trust Co. and State of Alaska Department of Revenue. View Insider Buying and Selling for BioTelemetry.

How do I buy BioTelemetry stock?

Shares of BioTelemetry can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BioTelemetry's stock price today?

One share of BioTelemetry stock can currently be purchased for approximately $34.40.


MarketBeat Community Rating for BioTelemetry (NASDAQ BEAT)
Community Ranking:  2.8 out of 5 ( )
Outperform Votes:  114 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  207
MarketBeat's community ratings are surveys of what our community members think about BioTelemetry and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for BioTelemetry (NASDAQ:BEAT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $39.50 (14.83% upside)

Analysts' Ratings History for BioTelemetry (NASDAQ:BEAT)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/19/2017Benchmark Co.Boost Price TargetBuy -> Buy$38.00 -> $44.00LowView Rating Details
7/14/2017Lake Street CapitalReiterated RatingBuy$35.00 -> $50.00HighView Rating Details
4/11/2017Dougherty & CoBoost Price TargetBuy -> Buy$30.00 -> $37.00LowView Rating Details
12/13/2016GabelliReiterated RatingBuyN/AView Rating Details
9/13/2016SidotiInitiated CoverageBuy$27.00N/AView Rating Details
(Data available from 7/23/2015 forward)

Earnings

Earnings History for BioTelemetry (NASDAQ:BEAT)
Earnings by Quarter for BioTelemetry (NASDAQ:BEAT)
Earnings History by Quarter for BioTelemetry (NASDAQ BEAT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/31/2017$0.21N/AView Earnings Details
5/3/2017Q1 2017$0.14$0.16$55.11 million$55.88 millionViewListenView Earnings Details
2/22/2017Q4 2016$0.18$0.23$53.75 million$53.96 millionViewListenView Earnings Details
11/2/2016Q316$0.18$0.21$52.92 million$53.10 millionViewN/AView Earnings Details
8/2/2016Q2$0.17$0.20$50.27 million$52.68 millionViewListenView Earnings Details
4/26/2016Q1$0.10$0.20$46.54 million$48.60 millionViewListenView Earnings Details
2/17/2016Q415$0.11$0.15$45.89 million$46.70 millionViewListenView Earnings Details
11/9/2015Q3$0.11$0.13$46.05 million$43.49 millionViewN/AView Earnings Details
8/6/2015Q2$0.09$0.12$45.75 million$44.81 millionViewListenView Earnings Details
5/6/2015Q115$0.02$0.06$43.80 million$43.40 millionViewListenView Earnings Details
2/19/2015Q414$0.06$0.05$43.40 million$43.70 millionViewListenView Earnings Details
10/30/2014Q214$0.01$0.06$42.00 million$43.00 millionViewListenView Earnings Details
7/31/2014Q114$0.01$0.02$40.95 million$42.70 millionViewListenView Earnings Details
5/6/2014Q413($0.02)($0.04)$38.40 million$37.16 millionViewListenView Earnings Details
2/26/2014Q313($0.04)$0.05$32.26 million$33.10 millionViewListenView Earnings Details
11/5/2013($0.05)($0.12)$32.79 million$31.90 millionViewListenView Earnings Details
7/30/2013Q2 2013$0.02$27.50 million$32.10 millionViewListenView Earnings Details
2/13/2013Q4 2012($0.09)$26.80 million$30.00 millionViewListenView Earnings Details
11/5/2012Q312($0.09)($0.08)$26.49 million$27.00 millionViewN/AView Earnings Details
8/8/2012($0.04)($0.01)ViewN/AView Earnings Details
5/8/2012($0.12)($0.10)ViewN/AView Earnings Details
2/22/2012($0.13)($0.04)ViewN/AView Earnings Details
11/8/2011($0.09)($0.21)ViewN/AView Earnings Details
8/8/2011($0.06)($0.05)ViewN/AView Earnings Details
5/3/2011($0.15)($0.02)ViewN/AView Earnings Details
2/17/2011($0.16)($0.13)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioTelemetry (NASDAQ:BEAT)
2017 EPS Consensus Estimate: $0.81
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.20$0.20$0.20
Q2 20171$0.20$0.20$0.20
Q3 20171$0.19$0.19$0.19
Q4 20171$0.22$0.22$0.22
(Data provided by Zacks Investment Research)

Dividends

Dividend History for BioTelemetry (NASDAQ:BEAT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for BioTelemetry (NASDAQ:BEAT)
Insider Ownership Percentage: 9.60%
Institutional Ownership Percentage: 79.75%
Insider Trades by Quarter for BioTelemetry (NASDAQ:BEAT)
Institutional Ownership by Quarter for BioTelemetry (NASDAQ:BEAT)
Insider Trades by Quarter for BioTelemetry (NASDAQ:BEAT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/15/2017Robert J. RubinDirectorSell15,000$28.14$422,100.00View SEC Filing  
3/20/2017Fred BroadwaySVPSell3,429$26.90$92,240.10View SEC Filing  
2/27/2017George HrenkoSVPSell126,043$25.95$3,270,815.85View SEC Filing  
2/21/2017Fred BroadwaySVPSell8,070$24.81$200,216.70View SEC Filing  
9/19/2016George HrenkoSVPSell1,061$18.50$19,628.50View SEC Filing  
9/13/2016Heather C GetzCFOSell5,866$18.23$106,937.18View SEC Filing  
9/13/2016Joseph H CapperInsiderSell26,847$18.23$489,420.81View SEC Filing  
9/13/2016Peter FerolaGeneral CounselSell4,352$18.23$79,336.96View SEC Filing  
9/9/2016Fred BroadwaySVPSell3,146$17.84$56,124.64View SEC Filing  
9/8/2016George HrenkoSVPSell3,491$18.06$63,047.46View SEC Filing  
9/8/2016Heather C GetzCFOSell2,979$18.10$53,919.90View SEC Filing  
9/8/2016Joseph H CapperInsiderSell13,632$18.10$246,739.20View SEC Filing  
9/8/2016Peter FerolaGeneral CounselSell2,210$18.10$40,001.00View SEC Filing  
9/7/2016Daniel WisniewskiSVPSell9,225$18.51$170,754.75View SEC Filing  
9/7/2016Heather C GetzCFOSell18,945$18.52$350,861.40View SEC Filing  
9/7/2016Joseph H CapperInsiderSell86,681$18.52$1,605,332.12View SEC Filing  
9/7/2016Peter FerolaGeneral CounselSell14,053$18.52$260,261.56View SEC Filing  
9/6/2016Fred BroadwaySVPSell4,662$18.28$85,221.36View SEC Filing  
9/6/2016Heather C GetzCFOSell6,686$18.29$122,286.94View SEC Filing  
9/6/2016Joseph H CapperCEOSell30,595$18.29$559,582.55View SEC Filing  
9/6/2016Peter FerolaGeneral CounselSell4,960$18.29$90,718.40View SEC Filing  
9/2/2016Fred BroadwaySVPSell4,466$18.75$83,737.50View SEC Filing  
9/2/2016Heather C GetzCFOSell6,547$18.75$122,756.25View SEC Filing  
9/2/2016Joseph H CapperCEOSell29,953$18.75$561,618.75View SEC Filing  
9/2/2016Peter FerolaGeneral CounselSell4,856$18.75$91,050.00View SEC Filing  
9/1/2016Fred BroadwaySVPSell7,525$19.25$144,856.25View SEC Filing  
9/1/2016Heather C GetzCFOSell10,408$18.59$193,484.72View SEC Filing  
9/1/2016Joseph H CapperInsiderSell47,622$18.59$885,292.98View SEC Filing  
9/1/2016Peter FerolaGeneral CounselSell7,722$18.59$143,551.98View SEC Filing  
8/30/2016Fred BroadwaySVPSell12,121$19.07$231,147.47View SEC Filing  
8/30/2016Heather C GetzCFOSell17,482$19.07$333,381.74View SEC Filing  
8/30/2016Joseph H CapperInsiderSell79,986$19.07$1,525,333.02View SEC Filing  
8/30/2016Peter FerolaGeneral CounselSell12,970$19.07$247,337.90View SEC Filing  
8/25/2016Fred BroadwaySVPSell5,877$19.16$112,603.32View SEC Filing  
8/25/2016Heather C GetzCFOSell8,477$19.16$162,419.32View SEC Filing  
8/25/2016Joseph H CapperInsiderSell38,785$19.16$743,120.60View SEC Filing  
8/25/2016Peter FerolaGeneral CounselSell6,289$19.16$120,497.24View SEC Filing  
8/24/2016George HrenkoSVPSell7,473$20.11$150,282.03View SEC Filing  
8/24/2016Heather C GetzCFOSell8,778$20.11$176,525.58View SEC Filing  
8/24/2016Joseph H CapperCEOSell40,160$20.11$807,617.60View SEC Filing  
8/24/2016Peter FerolaGeneral CounselSell6,512$20.11$130,956.32View SEC Filing  
8/23/2016George HrenkoSVPSell3,165$20.67$65,420.55View SEC Filing  
8/23/2016Heather C GetzCFOSell3,717$20.67$76,830.39View SEC Filing  
8/23/2016Joseph H CapperCEOSell17,008$20.67$351,555.36View SEC Filing  
8/23/2016Peter FerolaGeneral CounselSell2,758$20.67$57,007.86View SEC Filing  
8/22/2016George HrenkoSVPSell4,149$20.85$86,506.65View SEC Filing  
8/22/2016Heather C GetzCFOSell4,874$20.85$101,622.90View SEC Filing  
8/22/2016Joseph H CapperCEOSell22,298$20.85$464,913.30View SEC Filing  
8/22/2016Peter FerolaGeneral CounselSell3,616$20.85$75,393.60View SEC Filing  
8/19/2016Daniel WisniewskiSVPSell9,025$20.96$189,164.00View SEC Filing  
8/19/2016Heather C GetzCFOSell9,026$20.96$189,184.96View SEC Filing  
8/19/2016Joseph H CapperInsiderSell9,049$20.96$189,667.04View SEC Filing  
8/19/2016Peter FerolaGeneral CounselSell9,035$20.96$189,373.60View SEC Filing  
5/9/2014Ronald AhrensDirectorBuy6,000$7.37$44,220.00View SEC Filing  
11/12/2013Ronald AhrensDirectorBuy5,000$11.73$58,650.00View SEC Filing  
11/12/2012Ronald A AhrensDirectorBuy15,000$2.22$33,300.00View SEC Filing  
9/5/2012Joseph H CapperCEOBuy23,540$2.25$52,965.00View SEC Filing  
8/31/2012Joseph H CapperCEOBuy2,600$2.28$5,928.00View SEC Filing  
8/29/2012Joseph H CapperCEOBuy10,800$2.30$24,840.00View SEC Filing  
8/28/2012Joseph H CapperCEOBuy1,300$2.19$2,847.00View SEC Filing  
8/27/2012Joseph H CapperCEOBuy1,600$2.12$3,392.00View SEC Filing  
8/23/2012Joseph H CapperCEOBuy9,600$2.08$19,968.00View SEC Filing  
8/20/2012Joseph H CapperCEOBuy14,160$1.97$27,895.20View SEC Filing  
8/17/2012Joseph H CapperCEOBuy9,800$2.10$20,580.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for BioTelemetry (NASDAQ:BEAT)
Latest Headlines for BioTelemetry (NASDAQ:BEAT)
Source:
DateHeadline
americanbankingnews.com logoBioTelemetry, Inc. (BEAT) Price Target Increased to $44.00 by Analysts at Benchmark Co.
www.americanbankingnews.com - July 19 at 10:32 AM
nasdaq.com logoBioTelemetry, Inc. (BEAT) in Focus: Stock Moves 6.5% Higher - Nasdaq
www.nasdaq.com - July 17 at 4:45 PM
finance.yahoo.com logoBioTelemetry, Inc. (BEAT) in Focus: Stock Moves 6.5% Higher
finance.yahoo.com - July 17 at 12:29 PM
americanbankingnews.com logoBioTelemetry's (NASDAQ:BEAT) "Buy" Rating Reaffirmed at Lake Street Capital
www.americanbankingnews.com - July 15 at 10:53 PM
finance.yahoo.com logoS&P, Dow Reach Record Highs; 4 Top-Rated Stocks Hit Buy Points
finance.yahoo.com - July 14 at 6:24 PM
bizjournals.com logoBioTelemetry completes $280M acquisition - Philadelphia Business Journal
www.bizjournals.com - July 14 at 3:38 AM
finance.yahoo.com logoBioTelemetry completes $280M acquisition
finance.yahoo.com - July 13 at 5:28 PM
streetinsider.com logoBioTelemetry (BEAT) Completes Deal to Acquire LifeWatch AG
www.streetinsider.com - July 12 at 10:05 PM
globenewswire.com logoBioTelemetry, Inc. Completes LifeWatch AG Acquisition - GlobeNewswire (press release)
globenewswire.com - July 12 at 5:01 PM
feeds.benzinga.com logoBioTelemetry, Inc. Completes LifeWatch AG Acquisition
feeds.benzinga.com - July 12 at 12:44 PM
finance.yahoo.com logoETFs with exposure to BioTelemetry, Inc. : July 10, 2017
finance.yahoo.com - July 10 at 4:28 PM
globenewswire.com logoBioTelemetry, Inc. Reaches a Final Milestone in Acquisition of LifeWatch AG - GlobeNewswire (press release)
globenewswire.com - July 8 at 4:07 PM
nasdaq.com logoBioTelemetry, Inc. Reaches a Final Milestone in Acquisition of LifeWatch AG
www.nasdaq.com - July 8 at 9:08 AM
finance.yahoo.com logoBioTelemetry, Inc. Reaches a Final Milestone in Acquisition of LifeWatch AG
finance.yahoo.com - July 8 at 9:08 AM
americanbankingnews.com logoBioTelemetry, Inc. (NASDAQ:BEAT) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - July 3 at 2:32 PM
americanbankingnews.com logoReviewing BG Medicine (BGMD) & BioTelemetry (NASDAQ:BEAT)
www.americanbankingnews.com - July 2 at 10:28 PM
americanbankingnews.com logoBG Medicine (BGMD) & BioTelemetry (BEAT) Head to Head Contrast
www.americanbankingnews.com - July 1 at 4:04 PM
americanbankingnews.com logoBioTelemetry, Inc. (BEAT) Short Interest Update
www.americanbankingnews.com - June 30 at 7:18 AM
benzinga.com logoBenzinga's Top Upgrades, Downgrades For June 29, 2017 - Benzinga
www.benzinga.com - June 29 at 5:37 PM
americanbankingnews.com logoBenchmark Co. Begins Coverage on BioTelemetry, Inc. (BEAT)
www.americanbankingnews.com - June 29 at 9:00 AM
finance.yahoo.com logoETFs with exposure to BioTelemetry, Inc. : June 27, 2017
finance.yahoo.com - June 27 at 4:02 PM
americanbankingnews.com logoHead-To-Head Review: BioTelemetry (BEAT) & RadNet (RDNT)
www.americanbankingnews.com - June 25 at 7:54 AM
finance.yahoo.com logoBioTelemetry, Inc. breached its 50 day moving average in a Bullish Manner : BEAT-US : June 22, 2017
finance.yahoo.com - June 22 at 11:45 AM
americanbankingnews.com logoBioTelemetry (BEAT) and BG Medicine (BGMD) Head to Head Survey
www.americanbankingnews.com - June 13 at 12:54 AM
americanbankingnews.com logoBioTelemetry (BEAT) & BG Medicine (BGMD) Head to Head Contrast
www.americanbankingnews.com - June 13 at 12:54 AM
streetinsider.com logoBioTelemetry (BEAT) Says 82% of Outstanding LifeWatch AG ... - StreetInsider.com
www.streetinsider.com - June 10 at 3:53 PM
streetinsider.com logoBioTelemetry (BEAT) Says 82% of Outstanding LifeWatch AG Shares Have Been Tendered
www.streetinsider.com - June 9 at 4:25 PM
globenewswire.com logoBioTelemetry, Inc. Reaches Key Milestone in Tender Offer for LifeWatch AG
globenewswire.com - June 9 at 4:25 PM
finance.yahoo.com logoBioTelemetry, Inc. Reaches Key Milestone in Tender Offer for LifeWatch AG
finance.yahoo.com - June 9 at 4:25 PM
finance.yahoo.com logoBioTelemetry, Inc. breached its 50 day moving average in a Bullish Manner : BEAT-US : June 9, 2017
finance.yahoo.com - June 9 at 4:25 PM
finance.yahoo.com logoETFs with exposure to BioTelemetry, Inc. : June 8, 2017
finance.yahoo.com - June 8 at 4:40 PM
finance.yahoo.com logoBioTelemetry, Inc. :BEAT-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017
finance.yahoo.com - June 6 at 4:03 PM
finance.yahoo.com logoBioTelemetry, Inc. :BEAT-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017
finance.yahoo.com - June 6 at 4:03 PM
americanbankingnews.com logoBioTelemetry, Inc. (BEAT) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - June 6 at 2:38 PM
streetinsider.com logoBioTelemetry (BEAT) Says LifeWatch's Largest Shareholders ... - StreetInsider.com
www.streetinsider.com - May 30 at 8:56 PM
streetinsider.com logoBioTelemetry (BEAT) Says LifeWatch's Largest Shareholders Accepts Tender Offer
www.streetinsider.com - May 30 at 12:26 PM
finance.yahoo.com logoLifeWatch’s Largest Shareholders Accept BioTelemetry, Inc.’s Tender Offer for LifeWatch AG
finance.yahoo.com - May 30 at 12:26 PM
streetinsider.com logoBioTelemetry (BEAT) Increases Price, Extends Tender Offer Period for LifeWatch AG Shares
www.streetinsider.com - May 26 at 2:53 AM
globenewswire.com logoBioTelemetry, Inc. Increases Tender Offer Price and Extends Offer Period for LifeWatch AG Shares - GlobeNewswire (press release)
globenewswire.com - May 24 at 8:48 PM
streetinsider.com logoBioTelemetry (BEAT) Extends Tender Offer Period for LifeWatch AG Shares
www.streetinsider.com - May 24 at 11:49 AM
finance.yahoo.com logoBioTelemetry, Inc. Increases Tender Offer Price and Extends Offer Period for LifeWatch AG Shares
finance.yahoo.com - May 24 at 11:49 AM
nasdaq.com logoBioTelemetry, Inc. Announces Extension of the Tender Offer Period for LifeWatch AG Shares
www.nasdaq.com - May 23 at 11:18 AM
finance.yahoo.com logoBioTelemetry, Inc. Announces Extension of the Tender Offer Period for LifeWatch AG Shares
finance.yahoo.com - May 23 at 11:18 AM
americanbankingnews.com logoBioTelemetry, Inc. (BEAT) Director Robert J. Rubin Sells 15,000 Shares
www.americanbankingnews.com - May 16 at 7:32 PM
finance.yahoo.com logoBioTelemetry, Inc. breached its 50 day moving average in a Bearish Manner : BEAT-US : May 15, 2017
finance.yahoo.com - May 15 at 4:20 PM
americanbankingnews.com logoBioTelemetry, Inc. (BEAT) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 12 at 2:38 PM
finance.yahoo.com logoBioTelemetry, Inc. Announces the Start of the Tender Offer Period for LifeWatch AG Shares
finance.yahoo.com - May 10 at 8:53 AM
finance.yahoo.com logoBioTelemetry, Inc. – Value Analysis (NASDAQ:BEAT) : May 8, 2017
finance.yahoo.com - May 8 at 8:46 PM
streetinsider.com logoBioTelemetry (BEAT) Receives Antitrust Clearance for Acquisition of LifeWatch AG - StreetInsider.com
www.streetinsider.com - May 8 at 3:46 PM
americanbankingnews.com logoBioTelemetry, Inc. (BEAT) to Post FY2018 Earnings of $1.45 Per Share, Gabelli Forecasts
www.americanbankingnews.com - May 8 at 12:12 PM

Social

Chart

BioTelemetry (BEAT) Chart for Sunday, July, 23, 2017

This page was last updated on 7/23/2017 by MarketBeat.com Staff